On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
In 2002, the Virginia Commonwealth University (VCU) and INOVA Fairfax partnered to establish a medical program in Northern…
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
In 2002, Siemens, now Sivantos, launched Triano, the first hearing instrument with three microphones. This new hearing system…
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
On Oct. 8, 2001, Dr. Leland ‘Lee’ Hartwell from Fred Hutchinson Cancer Research Center was awarded the Nobel…
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
On May 5, 2001, molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University….
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…
In 2001, The February 16 issue of Science and February 15 issue of Nature contain the working draft…
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
On Jan. 12, 2001, Corus Pharma was incorporated as a private venture-backed development stage biopharmaceutical company focused on…
On Jan 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…